|
Volumn 4, Issue 1, 2008, Pages 19-21
|
Post-menopausal hormone therapy and cardiovascular events: A new paradigm based on pharmacogenetics?
|
Author keywords
Coronary heart disease; Estrogen; Glycoprotein; Hormone therapy; Pharmacogenetics; Platelets; Single nucleotide polymorphism
|
Indexed keywords
ACETYLSALICYLIC ACID;
ESTROGEN;
GESTAGEN;
GLYCOPROTEIN IB ALPHA;
GLYCOPROTEIN VI;
ARTERY DISEASE;
ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
GENE INTERACTION;
GENETIC ASSOCIATION;
GENETIC SUSCEPTIBILITY;
GENOTYPE;
HEART ARREST;
HEART DEATH;
HEART INFARCTION;
HORMONAL THERAPY;
HUMAN;
ISCHEMIC HEART DISEASE;
PHARMACOGENETICS;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
RISK REDUCTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
TRANSIENT ISCHEMIC ATTACK;
UNSTABLE ANGINA PECTORIS;
|
EID: 38049141573
PISSN: 14796678
EISSN: 17448298
Source Type: Journal
DOI: 10.2217/14796678.4.1.19 Document Type: Article |
Times cited : (1)
|
References (8)
|